KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cme Group (CME) Other Non Operating Income: 2009-2024

Historic Other Non Operating Income for Cme Group (CME) over the last 13 years, with Dec 2024 value amounting to -$3.7 billion.

  • Cme Group's Other Non Operating Income fell 51.80% to -$1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.4 billion, marking a year-over-year decrease of 16.55%. This contributed to the annual value of -$3.7 billion for FY2024, which is 22.06% up from last year.
  • As of FY2024, Cme Group's Other Non Operating Income stood at -$3.7 billion, which was up 22.06% from -$4.7 billion recorded in FY2023.
  • Cme Group's 5-year Other Non Operating Income high stood at $342.6 million for FY2021, and its period low was -$4.7 billion during FY2023.
  • Moreover, its 3-year median value for Other Non Operating Income was -$3.7 billion (2024), whereas its average is -$3.4 billion.
  • As far as peak fluctuations go, Cme Group's Other Non Operating Income surged by 379.90% in 2021, and later tumbled by 643.61% in 2022.
  • Cme Group's Other Non Operating Income (Yearly) stood at -$122.4 million in 2020, then soared by 379.90% to $342.6 million in 2021, then tumbled by 643.61% to -$1.9 billion in 2022, then tumbled by 152.09% to -$4.7 billion in 2023, then grew by 22.06% to -$3.7 billion in 2024.